Meet the team

ALEJANDRO TRINIDAD-FLORES. MBA

MANAGING DIRECTOR & CO-FOUNDER.

Alejandro Trinidad-Flores is a former Regional Marketing Manager at Amgen, strong marketing consultant, and seasoned project manager, with + 18 years of experience working for pharmaceutical companies, and leading cross-functional marketing teams in 21 countries (Canada, LATAM, Turkey, Middle East and Africa), with a track record of positive results.

Having held numerous Marketing Manager roles in pharmaceutical companies, he is very familiar with commercial strategies, project management, and best practices in the pharmaceutical industry.

In addition, Alejandro holds an MBA from the Anahuac University, a bachelor’s degree in Marketing and a Digital Marketing Certification from Columbia Business School.

LinkedIn Profile

www.linkedin.com/in/alejandro-trinidad-flores

Experience:

Amgen Inc. Thousand Oaks, CA. (2017-2019)

Responsible for leading the development and execution of marketing strategies in the Intercontinental Region for oncology and hematology assets (Filgrastim Franchise and Nplate®) in collaboration with regional partners in 21 countries (Canada, Latin America, Turkey, Middle East & Africa), supporting 14 Marketing Managers and 8 Business Unit Directors to ensure strategic and financial goals.

Amgen Inc. Thousand Oaks, CA. (2016-2017)

Accountable for the commercialization of Amgen portfolio in partnership with Latin-American Distributor Markets in a licensing model in 8 countries (Argentina, Chile, Peru, Ecuador, and Central America), to propose growth opportunities, support demand generation, estimate potential sales, monitor performance, propose, and manage the regional budget and ensure adherence to compliance.

Amgen. Mexico City, Mexico. (2012-2016)

Recognized for leading the launch of Prolia® in Mexico in 2012 in co-promotion between Amgen and GSK until the brand became the market share leader in 2016 (Private Segment in DOTs) with the highest Evolution Index and awarded in 2015 as Marketer of the Year.

Almirall. Mexico City, Mexico. (2011-2012)

Accountable for marketing strategies and tactical plans for respiratory system brands, focused on marketing plan, market research analysis, opinion leader engagement, product positioning, communication campaigns and development of marketing materials in collaboration with cross-functional teams and external vendors.

More Pharma. Mexico City, Mexico (2009-2011)

Responsible for marketing strategies for infectious disease and obesity brands in Latin America (Mexico, Central America, and Caribbean Region), in a start-up company focused on initiatives to support performance of mature brands after loss of exclusivity.

Eli Lilly and Company. Mexico City, Mexico (2007-2009)

Accountable for launching Cymbalta® in the indication of Fibromyalgia in co-promotion between Eli Lilly and Boehringer Ingelheim that resulted in sustainable growth, and long-term performance.

Eli Lilly and Company. Mexico City, Mexico (2003-2007)

Member of the neurosciences sales team that launched Strattera in 2003 and recognized as #1 market share territory for 3 consecutive years.

HELENA ZALDIVA-ALCANTARA M.D.

MEDICAL DIRECTOR

Helena Zaldivar-Alcantara is Medical Doctor, with specialty in Internal Medicine and subspecialty in Nephrology. She has practiced clinical medicine and has in clinical research. Helena has a strong scientific base, which has allowed her to successfully engage with healthcare professionals and international opinion leaders.

As a Regional Medical Liaison she simultaneously managed several projects beyond her core responsibilities, encompassing several therapeutic areas in Mexico and Intercontinental Region.

She has ample experience in developing and presenting educational resources, in the appropriate dissemination of clinical and scientific information in a timely, ethical and customer-focused manner, complying with pharmaceutical industry’s best practices.

LinkedIn Profile

linkedin.com/in/helena-zaldivar-aa306073

Experience:

Regional Medical Liaison Cardiovascular, AMGEN Mexico — 2016-2017.

Accountable for providing highly technical scientific information on PCSK9 to investigators and academic centers and developing national opinion leaders for scientific programs in preparation for the launch of Repatha in Mexico. Responsible mentoring and training of new hire RMLs in nephrology and cardiovascular therapeutic areas, sales force training, as well as RML Regional trainings (Latin America, Turkey, Africa, Middle East).

Regional Medical Liaison Nephrology, AMGEN Mexico — 2014-2016.

Developed and presented CME Programs for health care professionals in close collaboration with national medical and nurse associations in nephrology. Responsible for academic program, in compliance with best practices and budget management that were accredited by nephrology associations due to the fair, balanced and objective scientific information. Responsible for providing clinical information to payers and formulary decision makers, in cross-functional collaboration with marketing and market access teams, achieving inclusion of Mimpara/Sensipar and Aranesp in one of the main institutional formularies. Responsible for the organization of Advisory Boards and symposia during national congresses, engaging national and international opinion leaders. Presenter in symposia in national congresses. Preparation and review of scientific presentations for speakers, integrating balanced professional presentations while disseminating scientific data.

Clinical Education and Renal Therapy Specialist , Baxter Mexico — 2013-2014. Implementation and follow up of one national and one regional clinical program, developed to (1) improve peritoneal dialysis initiation and (2) decrease peritonitis rate according to international guidelines, based on Continuous Quality Improvement. Accountable for training of clinical sales force, database management and data analysis. Responsible for education and training of sales specialists in Renal Replacement Therapies (RRT), including expanded RRT-CRRT portfolio with Baxter-Gambro. Presenting disease management concepts in medical treatment to physicians, nurses, and patient support groups.

Teaching experience:

Professor of Nephrology — 2014-2016. School of Nursing, Instituto de Seguridad y Servicios Sociales de los trabajadores del Estado (ISSSTE). Curriculum for postgraduate education - Nephrology nurses. Basic anatomy and physiology, AKI, CKD and RRT.

Professor Advanced Training in Cardiology — 2008-2009. Superior School of Nursing and Obstetrics, Instituto Nacional de Cardiología Ignacio Chávez / Instituto Politécnico Nacional. Curriculum for specialized Operating Room nurses who assist in management of cardiopulmonary bypass machine during On-Pump bypass surgery.

Clinical Instructor Nephrology —2008-2009. School of Medicine, Universidad Panamericana

Pharmacology instructor — 2006–2008. Medical School, Universidad Nacional Autónoma de México

Internal Medicine clinical instructor — 2006–2008. Medical School, Universidad Nacional Autónoma de México

Publications:

Book chapters[Chapter 75: Subarachnoid hemorrhage; Neurology. Manual of medical therapeutics and emergency procedures], Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. 6 Ed. McGraw-Hill, México 2011

Scientific publications:

Zaldívar-Alcántara H, Herrera-Jiménez LE, Dehesa-López E, Correa-Rotter R.[Risk factors for the development of thrombotic complications in patients with systemic lupus erythematous and lupus nephropathy]. Rev Invest. Clin. 2013:65(3):199-208 zaguirre R, Zaldívar H. [Editorial: Fibrinogen as cardiovascular risk factor] Arch Cardiol Mex 2003;73 (1): 7-10

Clinical Research:

Rate of fibrin polymerization in patients with venous thromboembolism and cardiac embolism. 2002-2003 Hematology Department, Instituto Nacional de Cardiología Ignacio Chávez, México City, México.

Evaluation of the first year post preemptive renal transplant: Case-control study 2006-2007 Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubiran, México City, México.

Risk Factors for thromboembolic complications in patients with Systemic Lupus Erythematosus and Lupus Nephropathy 2007-2009. Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubiran, Mexico City, Mexico.